Department of Analytical Chemistry, Faculty of Chemistry, Seville, Spain.
Talanta. 2010 May 15;81(3):871-80. doi: 10.1016/j.talanta.2010.01.031. Epub 2010 Jan 25.
A new, accurate and sensitive reversed-phase high-performance liquid chromatography (RP-HPLC) as analytical method for the quantitative determination of 11 antibiotics (drugs) and the main metabolites of five of them present in human urine has been worked out, optimized and validated. The analytes belong to four different groups of antibiotics (sulfonamides, tetracyclines, penicillins and anphenicols). The analyzed compounds were sulfadiazine (SDI) and its N(4)-acetylsulfadiazine (NDI) metabolite, sulfamethazine (SMZ) and its N(4)-acetylsulfamethazine (NMZ), sulfamerazine (SMR) and its N(4)-acetylsulfamerazine (NMR), sulfamethoxazole (SMX), trimetroprim (TMP), amoxicillin (AMX) and its main metabolite amoxicilloic acid (AMA), ampicillin (AMP) and its main metabolite ampicilloic acid (APA), chloramphenicol (CLF), thiamphenicol (TIF), oxytetracycline (OXT) and chlortetracycline (CLT). For HPLC analysis, diode array (DAD) and fluorescence (FLD) detectors were used. The separation of the analyzed compounds was conducted by means of a Phenomenex Gemini C(18) (150mm x 4.6mm I.D., particle size 5microm) analytical column with LiChroCART LiChrospher C(18) (4mm x 4mm, particle size 5microm) guard column. Analyzed drugs were determined within 34min using formic acid 0.1% in water and acetonitrile in gradient elution mode as mobile phase. A linear response was observed for all compounds in the range of concentration studied. Two procedures were optimized for sample preparation: a direct treatment with methanol and acetonitrile and a solid phase extraction procedure using Bond Elut Plexa columns. The method was applied to the determination of the analytes in human urine from volunteers under treatment with different pharmaceutical formulations. This method can be successfully applied to routine determination of all these drugs in human urine samples.
已经开发、优化和验证了一种新的、准确且灵敏的反相高效液相色谱 (RP-HPLC) 分析方法,用于定量测定人尿中 11 种抗生素(药物)及其 5 种主要代谢物。分析物属于四类不同的抗生素(磺胺类、四环素类、青霉素类和安非他命类)。分析的化合物有磺胺嘧啶 (SDI) 和其 N(4)-乙酰磺胺嘧啶 (NDI) 代谢物、磺胺甲噁唑 (SMZ) 和其 N(4)-乙酰磺胺甲噁唑 (NMZ)、磺胺二甲嘧啶 (SMR) 和其 N(4)-乙酰磺胺二甲嘧啶 (NMR)、磺胺甲噁唑 (SMX)、三甲氧苄氨嘧啶 (TMP)、阿莫西林 (AMX) 和其主要代谢物阿莫西林酸 (AMA)、氨苄西林 (AMP) 和其主要代谢物氨苄西林酸 (APA)、氯霉素 (CLF)、硫霉素 (TIF)、土霉素 (OXT) 和金霉素 (CLT)。用于 HPLC 分析的是二极管阵列 (DAD) 和荧光 (FLD) 检测器。使用 Phenomenex Gemini C(18)(150mm x 4.6mm ID,粒径 5μm)分析柱和 LiChroCART LiChrospher C(18)(4mm x 4mm,粒径 5μm)保护柱对分析物进行分离。在梯度洗脱模式下,以 0.1%甲酸水和乙腈作为流动相,在 34min 内完成了分析物的分离。所有化合物在研究浓度范围内均表现出线性响应。对样品制备进行了两种优化程序:甲醇和乙腈直接处理和 Bond Elut Plexa 柱固相萃取程序。该方法应用于志愿者经不同药物制剂治疗后的尿液中分析物的测定。该方法可成功应用于人尿样中所有这些药物的常规测定。